forum

SYNCOM Share Price Discussion

Syncom Healthcare Ltd.
Sector: Pharmaceuticals and health care
... Read more
SYNCOM Share Price *
0 +0 (0%)
* (quote may be delayed)

SYNCOM Discussion Forum

Like
reply
Reply
share
Share
  • SYNCOM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization8.16
    Enterprise Value30.68
    Price to Earnings168.52
    Price to Book Value1.83
    Return on Capital Employed-1.89
    Return on Equity-6.6
    Face Value10
    Dividend YieldNA
  • SYNCOM Share Price - Technicals

    keyboard_arrow_down
    SYNCOM - 52 Week High₹4.7
    SYNCOM - 52 Week Low₹2.35
  • SYNCOM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 113.53.53.153.3
    Jan 103.253.53.23.4
    Jan 93.053.353.053.25
    Jan 83.053.13.053.05
    Jan 73.13.153.053.05
  • SYNCOM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹3.21
    30 Day Moving Average₹3.21
    50 Day Moving Average₹3.26
    100 Day Moving Average₹3.51
    200 Day Moving Average₹4.07
  • SYNCOM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue4253.22-0.21
    Operating Profit-5-69.56-0.93
    Profit Before Tax-66-75.97-0.13
    Net Income-66-83.88-0.21
  • SYNCOM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds-0.910-1.09
    Total Liabilities50.3651-0.01
    Total Assets49.4661-0.19
  • SYNCOM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity613.19-0.55
    Cash from Investing Activity-1-3.85-0.74
    Cash from Financing Activity-5-9.94-0.5
    Net Cash FlowNA-0.6-1
  • SYNCOM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-1.08-0.71
    Return on Equity-6.6-1.1
    Return on Capital Employed-1.89-0.71
  • SYNCOM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.32
    3 Year CAGR Growth in Operating Profit-4.21
    3 Year CAGR Growth in EBIDTA-421.69
    3 Year CAGR Growth in Net Income-16.28
    3 Yr CAGR Growth - Diluted EPS-16.19
  • SYNCOM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.55
    5 Year CAGR Growth in Operating Profit-2.33
    5 Year CAGR Growth in EBIDTA-12.55
    5 Year CAGR Growth in Net Income-287.96
    3 Yr CAGR Growth - Diluted EPS-276
  • SYNCOM Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    May 30 11:23 PM
    NewsBot
    Feb 11 6:57 PM
    NewsBot
    Nov 9 8:47 PM
  • SYNCOM - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.